Copeland Capital Management LLC Cuts Stock Position in Encompass Health Corporation (NYSE:EHC)

Copeland Capital Management LLC cut its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 2.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,263,771 shares of the company's stock after selling 29,327 shares during the quarter. Encompass Health comprises 2.6% of Copeland Capital Management LLC's investment portfolio, making the stock its biggest holding. Copeland Capital Management LLC owned approximately 1.25% of Encompass Health worth $127,995,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. US Bancorp DE boosted its holdings in shares of Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after buying an additional 121 shares in the last quarter. Signaturefd LLC lifted its position in Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after acquiring an additional 125 shares during the period. CBIZ Investment Advisory Services LLC lifted its position in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after acquiring an additional 127 shares during the period. SPC Financial Inc. lifted its position in Encompass Health by 0.3% during the 4th quarter. SPC Financial Inc. now owns 45,077 shares of the company's stock valued at $4,163,000 after acquiring an additional 154 shares during the period. Finally, Merit Financial Group LLC grew its position in Encompass Health by 4.1% during the 1st quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock valued at $427,000 after purchasing an additional 166 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Performance

Shares of NYSE:EHC traded up $0.55 during trading on Friday, hitting $122.09. The company's stock had a trading volume of 1,256,669 shares, compared to its average volume of 704,613. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06. The firm has a market cap of $12.31 billion, a price-to-earnings ratio of 25.22, a P/E/G ratio of 2.48 and a beta of 0.89. The company has a 50-day moving average of $117.60 and a 200-day moving average of $104.65. Encompass Health Corporation has a 12 month low of $82.74 and a 12 month high of $123.13.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The company's revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.12 EPS. On average, sell-side analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.56%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on EHC shares. Royal Bank Of Canada upped their target price on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a report on Thursday, June 5th. Barclays increased their price objective on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. Finally, Truist Financial reissued a "buy" rating and issued a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Eight investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $127.00.

Insider Activity at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the sale, the executive vice president now directly owns 79,710 shares of the company's stock, valued at $9,149,910.90. This trade represents a 11.15% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the sale, the chief executive officer now owns 527,070 shares in the company, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 132,663 shares of company stock worth $16,034,082. 2.00% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.